Co-op – Clinical Bioanalytics
Confirmed live in the last 24 hours
Pioneering precision genetic medicines through CRISPR base editing
Company Overview
Beam Therapeutics, established in 2018, is a pioneer in the field of genetic medicine, utilizing CRISPR base editing to create precise, permanent alterations to single bases in DNA and RNA without breaking the strands. The company's culture is characterized by a community of fearless innovators, rigorous and honest research, open-mindedness, and commitment to each other. Their competitive advantage lies in their unique delivery strategy, which includes a range of clinically validated technologies such as electroporation, nonviral, and viral delivery modalities, positioning them as a leader in the genetic medicine industry.
Biotechnology
Company Stage
IPO
Total Funding
$689M
Founded
2017
Headquarters
Cambridge, Massachusetts
Growth & Insights
Headcount
6 month growth
↓ -4%1 year growth
↑ 0%2 year growth
↑ 57%Locations
Cambridge, MA, USA
Experience Level
Intern
Desired Skills
Data Analysis
CategoriesNew
Biology & Biotech
Requirements
- Working towards a bachelor's or a graduate degree in biological science or related field
- Completion of biology or related lab course is highly desirable
- Broad understanding of drug discovery and development process and working knowledge of biochemical & molecular biology methods used in drug development
Responsibilities
- Develop Clinical pharmacokinetic/pharmacodynamic using different assay platforms such as Taqman qPCR, ELISA etc
- Evaluation of technologies, trouble shooting of assays, data analysis and interpretation
- Presentation of work in group meetings
- Maintain clear notebook and documentation practices